These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Regulating compounding pharmacies after NECC. Outterson K N Engl J Med; 2012 Nov; 367(21):1969-72. PubMed ID: 23134357 [No Abstract] [Full Text] [Related]
3. The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives. Blankenship C Int J Pharm Compd; 2018; 22(1):26-28. PubMed ID: 29385383 [No Abstract] [Full Text] [Related]
5. FDA inspections find unsafe practices in compounding pharmacies. McCarthy M BMJ; 2013 Apr; 346():f2414. PubMed ID: 23592476 [No Abstract] [Full Text] [Related]
6. Drug compounding, drug safety, and the first amendment. Dresser R Hastings Cent Rep; 2013; 43(2):9-10. PubMed ID: 23494695 [No Abstract] [Full Text] [Related]
7. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies. Kastango ES JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322 [TBL] [Abstract][Full Text] [Related]
8. Looking for solutions. Menighan TE Int J Pharm Compd; 2013; 17(1):4. PubMed ID: 23627240 [No Abstract] [Full Text] [Related]
9. Regulators faulted for inadequate compounding pharmacy oversight. Traynor K Am J Health Syst Pharm; 2013 Jan; 70(1):8-10. PubMed ID: 23261891 [No Abstract] [Full Text] [Related]
10. International Academy of Compounding Pharmacists' recommendations for state-based legislative and regulatory initiatives. Miller DG Int J Pharm Compd; 2013; 17(1):48-9. PubMed ID: 23627246 [No Abstract] [Full Text] [Related]
11. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies. Hinkley KN State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443 [No Abstract] [Full Text] [Related]
12. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists. Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883 [No Abstract] [Full Text] [Related]
13. Compounding pharmacies: who is in charge? Pergolizzi JV; Labhsetwar S; LeQuang JA Pain Pract; 2013 Mar; 13(3):253-7. PubMed ID: 23350709 [TBL] [Abstract][Full Text] [Related]
14. 2013 State Compounding Legislation Tracker. Miller DG Int J Pharm Compd; 2013; 17(5):375-8. PubMed ID: 24459782 [No Abstract] [Full Text] [Related]
15. The drug quality and security act: how will it change pharmacy? Soukup BJ Consult Pharm; 2014; 29(5):352. PubMed ID: 25203978 [No Abstract] [Full Text] [Related]
17. From the Food and Drug Administration. Crawford LM JAMA; 2002 Oct; 288(13):1579. PubMed ID: 12350176 [No Abstract] [Full Text] [Related]
18. Under scrutiny. More control of compounding pharmacies sought. Lee J Mod Healthc; 2012 Oct; 42(43):12-3. PubMed ID: 23163094 [No Abstract] [Full Text] [Related]
19. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies. Yoch D Int J Pharm Compd; 2017; 21(2):95-102. PubMed ID: 28346203 [TBL] [Abstract][Full Text] [Related]
20. The "Lists": What Do They Mean? Voliva J Int J Pharm Compd; 2016; 20(6):477-479. PubMed ID: 28339386 [No Abstract] [Full Text] [Related] [Next] [New Search]